Good Medicine Podcast

In this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a revealing discussion on one of the most important—and misunderstood—topics in modern health: chronic inflammation. Together, they unpack the crucial difference between acute and chronic inflammation, explain why long-term inflammation is a silent driver behind a wide range of serious diseases, and explore how shifting our medical approach could transform outcomes.Whether you're a healthcare professional, wellness enthusiast, or someone navigating chronic illness, this episode offers powerful insights into the role inflammation plays in everything from heart disease to neurodegeneration—and why understanding it could be the key to prevention.

In this episode of Good Medicine, Dr. David Bearss sits down with Matt Bresnahan, a partner at Wilson Sonsini Goodrich & Rosati, to demystify the world of patents in biotech and life sciences. Together, they explore what makes an innovation patent-eligible, how the 21-year patent timeline works, and how the U.S. patent system incentivizes solving unmet medical needs—ultimately helping patients access breakthrough drugs at lower costs.Whether you're a biotech founder, researcher, or just curious about how innovation becomes accessible medicine, this episode offers clear, practical insight into one of the most important—but misunderstood—parts of the life sciences ecosystem.🔗 New episodes every Tuesday. Subscribe to stay in the loop on healthcare, innovation, and policy.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

Dr. David Bearss sits down with Daniel Evans of Southern Star Research to explore how Australia is becoming a global leader in Phase 1 clinical trials. They discuss how the country’s streamlined regulatory environment and government incentives are helping biotech companies move faster and more efficiently. Australia’s bold approach is challenging outdated global standards. If you’re in biotech, pharma, or curious about the future of clinical research, this episode offers a glimpse into a more agile, innovative path forward.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

On this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a raw and insightful conversation about obesity, weight loss, and the explosive rise of GLP-1 drugs.Together, they explore:The personal and societal toll of obesityHow GLP-1 medications are reshaping the weight loss landscapeThe science behind these treatments — and the hypeWhy lifestyle still matters, even in a pharmaceutical eraSubscribe for more real, honest conversations about health, innovation, and the future of medicine.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on Good Medicine, we sit down with Henry O’Connell, CEO of Canary Speech, a company using vocal biomarkers to revolutionize mental and neurological health diagnostics.With a career spanning leadership roles at NIH, HP, and MOXTEK, Henry brings decades of insight into how technology can transform healthcare. In this episode, he explains how Canary’s voice analysis tools are giving doctors a clearer picture of patient health, removing global bias from diagnostics, and helping parents better support their kids’ emotional well-being.🔍 We explore:How vocal data can complement traditional medical toolsThe role of AI in detecting mental health conditionsMaking healthcare more equitable across cultures and regionsEmpowering parents with real-time emotional insightsWhether you're a clinician, innovator, or just curious about the future of healthcare, this conversation offers a fascinating look at how something as simple as your voice could shape the next era of medicine.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of Good Medicine, David Bearss sits down with John Lippert, founder and Chief Technology Officer at Scientia. With a career spanning decades in the medical device industry, John shares insights from his work in neurovascular innovation, startup leadership, and the evolution of less-invasive medicine. As the founder of both Scientia Vascular and Precision Vascular Systems—and with a background at leading companies like Target Therapeutics and Advanced Cardiovascular Systems—John brings a rare depth of technical expertise and entrepreneurial vision.We explore his impressive portfolio of patents, his approach to building breakthrough technologies, and the values that have guided his journey from engineer to industry leader.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this episode of Good Medicine, Dr. Bearss sits down with Mark Paul, a veteran of the medical device industry, to explore the intersection of innovation, engineering, and patient care.Mark shares lessons from a decades-long career — from early product development to scaling companies that have improved countless lives. He reflects on the mindset needed to lead teams, solve real-world problems, and bring new devices to market. It's a rare look behind the curtain of medtech from someone who’s lived it.Whether you're an engineer, healthcare investor, startup founder, or just fascinated by the tools that keep people alive and thriving, this is an episode packed with insight and inspiration.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on Good Medicine, Dr. David Bearss dives into the roles of the FDA and NIH in today’s healthcare landscape. He explores the vital impact these institutions have on innovation, safety, and public trust—while also examining the growing debates around how they operate. From differing perspectives across industry, academia, and government, Dave unpacks the complex views on what should evolve and why it matters.Whether you're in biotech, policy, or just curious about the forces shaping medicine, this episode offers a grounded, insightful look at two of the most influential organizations in health.SponsorsBioHive: ⁠https://www.biohive.comGalvan: https://www.galvan.healthFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePodTikTok: ⁠https://www.tiktok.com/@good.medicine.podcastLinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/

In this episode of Good Medicine, Dr. Bearss sits down with Dr. Ryan Watts, CEO of Denali Therapeutics, to explore the cutting edge of neurodegenerative disease research.They dive deep into the science behind treating Alzheimer’s, Parkinson’s, ALS, and other brain disorders — including how Denali is tackling one of the biggest challenges in medicine: getting therapies across the blood-brain barrier.Topics include:- Why the brain is uniquely hard to treat- How genetics and biomarkers are shaping drug development- Denali’s approach to targeted therapeutics and clinical trials- The future of neuroscience and precision medicineWhether you’re a scientist, student, investor, or just curious about how modern biotech is taking on brain disease, this is a conversation you don’t want to miss.Sponsors BioHive: ⁠https://www.biohive.com/⁠ Galvan: https://www.galvan.health/ Follow Good Medicine Podcast Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

In this solo episode, Dr. Bearss breaks down the controversial “Most Favored Nation” (MFN) drug pricing rule introduced during the Trump administration. What is the policy aiming to solve? How would it change the cost of prescription drugs in the U.S.? And why did it stir such intense debate across the healthcare and pharmaceutical industries?With clear, research-backed insight, David explores the economic and political implications of MFN, how it compares to international drug pricing models, and what it tells us about the future of healthcare reform in America.Whether you’re in healthcare, policy, or just trying to make sense of why your prescriptions cost so much, this is a must-listen.Sponsors BioHive: ⁠https://www.biohive.com/⁠ Galvan: https://www.galvan.health/ Follow Good Medicine Podcast Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/⁠